Cardiovascular disease is a leading cause of death in women, nevertheless it is often underestimated in female patients without overt risk factors. The chronic infection by Human Immunodeficiency Virus (HIV) is clearly associated, along with the use of certain antiretroviral drugs and traditional risk factors, with an increased risk of cardiovascular diseases. The aim of this manuscript is to review the epidemiology, risk factors, pathogenesis, diagnostic approach, primary and secondary prevention strategies of cardiovascular disease in HIV-negative and HIV-positive female subjects. The ultimate goal is to promote knowledge and development of specific and appropriate clinical interventions and guidelines in this group of high-risk patients, mostly in view of the expected growth of ageing females with HIV.

Cardiovascular disease in women with HIV-1 infection / M. Volpe, A. Uglietti, A. Castagna, C. Mussini, G. Marchetti, R. Bellagamba, T. Bini, D. Mancusi, R. Termini. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 241:(2017 Aug), pp. 50-56. [10.1016/j.ijcard.2017.02.117]

Cardiovascular disease in women with HIV-1 infection

G. Marchetti;
2017

Abstract

Cardiovascular disease is a leading cause of death in women, nevertheless it is often underestimated in female patients without overt risk factors. The chronic infection by Human Immunodeficiency Virus (HIV) is clearly associated, along with the use of certain antiretroviral drugs and traditional risk factors, with an increased risk of cardiovascular diseases. The aim of this manuscript is to review the epidemiology, risk factors, pathogenesis, diagnostic approach, primary and secondary prevention strategies of cardiovascular disease in HIV-negative and HIV-positive female subjects. The ultimate goal is to promote knowledge and development of specific and appropriate clinical interventions and guidelines in this group of high-risk patients, mostly in view of the expected growth of ageing females with HIV.
cardiovascular disease; cardiovascular prevention; HIV; risk factors; women; antiretroviral therapy, highly active; cardiovascular diseases; female; HIV infections; humans; primary prevention; risk factors; HIV-1; cardiology and cardiovascular medicine
Settore MED/17 - Malattie Infettive
ago-2017
27-feb-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0167527316342413-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 491.91 kB
Formato Adobe PDF
491.91 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/565409
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 14
social impact